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doi:10.1Objective: This study examines the association of hospital coronary artery bypass procedural volume with
mortality, morbidity, evidence-based care processes, and Society of Thoracic Surgeons composite score.
Methods: The study population consisted of 144,526 patients from 733 hospitals that submitted data to the Society
of Thoracic Surgeons Adult Cardiac Database in 2007. End points included use of National Quality Forum–en-
dorsed process measures (internal thoracic artery graft; preoperative b-blockade; and discharge b-blockade, anti-
platelet agents, and lipid drugs), operative mortality (in-hospital or 30-day), major morbidity (stroke, renal failure,
reoperation, sternal infection, and prolonged ventilation), and Society of Thoracic Surgeons composite score. Pro-
cedural volume was analyzed as a continuous variable and by volume strata (<100, 100–149, 150–199, 200–299,
300–449, and 450). Analyses were performed with logistic and multivariate hierarchical regression modeling.
Results: Unadjusted mortality decreased across volume categories from 2.6% (<100 cases) to 1.7% (>450
cases, P< .0001), and these differences persisted after risk factor adjustment (odds ratio for lowest- vs high-
est-volume group, 1.49). Care processes and morbidity end points were not associated with hospital procedural
volume except for a trend (P ¼ .0237) toward greater internal thoracic artery use in high-volume hospitals. The
average composite score for the lowest volume (<100 cases) group was significantly lower than that of the 2
highest-volume groups, but only 1% of composite score variation was explained by volume.
Conclusion:A volume–performance association exists for coronary artery bypass grafting but is weaker than that
of other major complex procedures. There is considerable outcomes variability not explained by hospital volume,
and low volume does not preclude excellent performance. Except for internal thoracic artery use, care processes
and morbidity rates were not associated with volume. (J Thorac Cardiovasc Surg 2010;139:273-282)Earn CME credits at
http://cme.ctsnetjournals.org
Subsequent to the pioneering work of Luft et al,1 volume has
commonly been used as a structural measure of health care
quality, particularly when more direct measures are either un-
available or unreliable because of small sample sizes. Although
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The Journal of Thoracic and Caobserved for many procedures, including coronary artery by-
pass grafting (CABG) procedures, few studies have examined
the associations between volume and more comprehensive
measures of provider performance. Furthermore, even more re-
cent studies of the CABG volume–mortality association are
based on data that are now nearly a decade old2,3 and might
not reflect current practice, particularly given the marked de-
crease in average CABG volume at most hospitals.
This study uses contemporary, national clinical data to ex-
amine the association between hospital CABG volume and
the Society of Thoracic Surgeons (STS) CABG composite
score, as well as its 4 performance domains: (1) operative
mortality; (2) major morbidity; (3) operative care; and (4)
perioperative medications. The STS CABG composite score
has been in use since 2007 and is arguably the most compre-
hensive, multidimensional measure of CABG performance
currently available.4,5MATERIALS AND METHODS
Study Population
The study population consists of adults (age, 20–100 years) who
underwent isolated CABG surgery at an STS Adult Cardiac Database
(ACDB)–participating hospital between January 1, 2007, and December
31, 2007. Among 154,210 eligible CABG operations, we excluded 415rdiovascular Surgery c Volume 139, Number 2 273
Abbreviations and Acronyms
ACDB ¼ Adult Cardiac Database
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
ITA ¼ internal thoracic artery
STS ¼ Society of Thoracic Surgeons
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Dcases for which the hospital could not be determined and an additional 8854
records from 103 hospitals that submitted data for only part of 2007. Three
hospitals were excluded (n ¼ 384 patients) because of high frequency
(>5%) of missing data for National Quality Form (NQF) medication mea-
sures. Finally, we excluded 7 patients with missing sex and 24 patients
whose data were submitted in a format other than STS version 2.52. The fi-
nal study population consists of 144,526 patients from 733 hospitals.
There were several analysis-specific exclusion criteria: (1) patients with
preoperative renal failure were excluded when analyzing postoperative re-
nal failure; (2) patients with preoperative cerebrovascular accidents were ex-
cluded when analyzing stroke; (3) patients with prior CABG were excluded
when analyzing internal thoracic artery (ITA) use; and (4) patients who died
in the hospital were excluded when analyzing discharge medications.
Unit of Inference
The unit of inference for this study of CABG volumes is a hospital. This
is a departure from some previous STS analyses based on ‘‘STS partici-
pant.’’ Hospital was chosen over participant because the latter can consist
of multiple hospitals and surgeon groups. Hospital volume was also chosen
to be consistent with existing volume–outcome studies and because it might
be more relevant to the study of system-level effects.
Hospital Identification
Hospitals were identified by using the participant ID, hospital name, hos-
pital ZIP code, and hospital state database fields. Ambiguous hospital names
were adjudicated by using information from hospital Web sites and direct
communication with STS data managers at participating hospitals.
Primary Independent Variable: CABG Volume
Hospital CABG volumes were calculated based on the 2007 calendar
year after preliminary studies showed near-perfect (r ¼ 0.994) correlation
between 1-year (2007) and 2-year (2006–2007) volumes. For the purpose
of defining hospital volume, all cases with CABG were counted, including
CABG performed in combination with other cardiac or noncardiac proce-
dures. The presumption was that all CABG cases, even when combined
with other procedures, still afforded experience in CABG techniques. How-
ever, after determining total CABG case volumes, all subsequent analyses
were restricted to patients undergoing isolated CABG. Patients undergoing
concomitant procedures (eg, valve surgery) were excluded.
Analyses were performed with volume both as a continuous and categor-
ical variable. Cut points for the latter (<100, 100–149, 150–199, 200–299,
300–449, and450 total CABG cases) were selected after considering both
previous studies and the empiric distribution of hospital volumes in our
study population.
Primary End Points
Study end points include the overall STS composite CABG score, as well
as the 4 performance domains and 11 individual NQF-endorsed measures
from which it is derived: (1) all-cause operative mortality (in-hospital death
regardless of timing and 30-day death regardless of venue); (2) major mor-
bidity (both individual outcomes and any-or-none occurrence of the follow-274 The Journal of Thoracic and Cardiovascular Surging: renal failure, re-exploration, stroke, sternal infection, or prolonged
ventilation); (3) failure to use at least 1 ITA bypass graft conduit; and (4)
failure to use recommended perioperative medications (preoperative b-
blockade and discharge antiplatelets, lipid-lowering agents, and b-blockade)
both individually and as part of an all-or-none medication domain.
Definitions of these end points were consistent with the report of the STS
Quality Measurement Task Force report on composite measures4,5 and
with version 2.52 of the STS ACDB.
Model Covariates
Covariates for the patient-level hierarchical logistic regression models
included all variables in the STS 2008 CABG mortality model6 plus month
of surgical intervention (to account for secular declining trends in mortality,
which were small during the 1-year study period).
Analyses
The number of hospitals and patients, the distribution of preoperative pa-
tient characteristics, and unadjusted performance rates were determined for
each 2007 volume category.
Scatterplots were constructed of unadjusted domain scores and STS
composite scores plotted against total hospital CABG volume as a continu-
ous rather than categorical variable.
Random-effects logistic regression was performed with SAS GLIMMIX
(SAS Institute, Inc, Cary, NC) to compare the frequency of adverse out-
comes across volume categories, accounting for case mix and clustering.
Odds ratios and confidence intervals (CIs) were calculated for each adverse
outcome and volume category relative to the performance of hospitals with
450 or more CABG procedures. Unlike the method originally used to de-
velop the STS composite score,4 these models were fit by using individual
patient-level data and not aggregated to the level of hospitals.
Random-effects logistic regression models were also fit using volume as
a continuous rather than categorical variable. To allow for possible nonlinear
effects, volume was modeled by using restricted cubic splines with
a reference point of 500 CABG procedures and knots at 150, 300, and
450. Sensitivity to the choice of knot locations was assessed by refitting
the models with knots at various percentiles of the empirical distribution
of hospital volume. The shape of the estimated volume–outcome association
was generally consistent across these different model specifications, and
therefore only the first set of results are presented. Seven hospitals with
volumes in excess of 1000 CABG procedures are not included in these plots,
but their data were included in the analyses.
A multivariate hierarchical random-effects model for the composite
CABG score was estimated by using WinBUGS software (Appendix 1).7
The reported estimates are based on the Bayesian posterior distribution
and are accompanied by Bayesian 95% credible intervals.
Using previously described methodology,4,5 the STS star rating was de-
termined for each hospital, and the scores were plotted against the hospital
volume category. A 1-star rating indicates a 99% Bayesian probability that
a hospital’s composite score is lower than the STS average (2-star rating),
and a 3-star rating indicates a 99% Bayesian probability that a hospital’s
composite score exceeds the STS average.
Missing Data
Missing data were managed by using multiple imputation, as imple-
mented in SAS PROC MI with the MCMC option. We assumed data
were missing at random, implying that conditional on all the observed
data available to us, the missing data mechanism did not depend on the ac-
tual value of the missing variable.RESULTS
Table 1 demonstrates the distribution of hospitals and iso-
lated CABG procedures among 6 hospital volumeery c February 2010
TABLE 1. Distribution of hospitals, patients, and unadjusted performance results by volume category
Hospital volume category
All <100 100–149 150–199 200–299 300–449 450
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Hospitals 733 (100) 134 (18.3) 128 (17.5) 108 (14.7) 157 (21.4) 114 (15.6) 92 (12.6)
Patients 144,526 (100) 8056 (5.6) 12,740 (8.8) 14,789(10.2) 30,209(20.9) 31,585(21.9) 47,147(32.6)
Domain results % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) P value for
trend
Mortality 2.0
(1.9–2.1)
2.6
(2.2–3.0)
2.3
(2.0–2.6)
2.1
(1.8–2.4)
2.2
(2.0–2.4)
2.0
(1.9–2.2)
1.7
(1.5–1.9)
<.0001
Morbidity 13.8
(13.3–14.3)
14.8
(13.4–16.1)
14.2
(13.0–15.4)
13.9
(13.0–14.9)
13.9
(13.0–14.8)
14.0
(13.0–15.0)
13.2
(12.2–14.3)
.1129
ITA failure 6.1
(5.7–6.5)
6.8
(5.7–7.9)
6.8
(5.7–8.0)
6.5
(5.3–7.7)
6.5
(5.7–7.3)
5.4
(4.6–6.2)
5.8
(4.9–6.7)
.0456
Med failure 36.7
(35.5–38.0)
38.4
(35.4–41.4)
35.5
(33.0–38.0)
36.7
(34.0–39.4)
36.5
(34.1–38.8)
35.8
(33.0–38.5)
37.5
(34.8–40.3)
.7672
Morbidity measures
Prolonged
ventilation
9.2 (8.7–9.7) 9.9 (8.8–11.0) 9.7 (8.6–10.8) 9.1 (8.1–10.0) 9.3 (8.5–10.1) 9.4 (8.4–10.4) 8.8 (7.8–9.9) .2403
DSWI 0.3 (0.3–0.4) 0.3 (0.2–0.4) 0.5 (0.3–0.6) 0.3 (0.2–0.4) 0.3 (0.2–0.3) 0.4 (0.3–0.5) 0.4 (0.3–0.4) .8004
Stroke 1.0 (0.9–1.0) 0.9 (0.7–1.2) 0.9 (0.7–1.1) 1.1 (0.9–1.3) 1.0 (0.8–1.1) 1.0 (0.9–1.1) 0.9 (0.8–1.1) .6721
Renal failure 3.0 (2.9–3.2) 3.4 (2.9–3.9) 3.1 (2.6–3.5) 3.1 (2.7–3.5) 3.1 (2.8–3.5) 3.2 (2.9–3.6) 2.7 (2.4–3.0) .0314
Reoperation 5.1 (4.9–5.3) 5.4 (4.7–6.1) 5.1 (4.4–5.7) 5.1 (4.6–5.6) 5.0 (4.5–5.4) 5.2 (4.8–5.7) 5.0 (4.5–5.5) .606
Medication failure
Preop b-blockade 22.2
(21.3–23.2)
22.3
(20.3–24.3)
21.8
(20.1–23.5)
22.0
(20.2–23.8)
22.6
(20.9–24.3)
21.1
(18.9–23.3)
23.0
(20.9–25.1)
.6128
D/C antiplatelet 4.3
(3.7–5.0)
5.7
(3.3–8.0)
3.7
(3.0–4.3)
3.3
(2.8–3.9)
4.0
(3.4–4.5)
4.2
(3.6–4.8)
4.9
(3.0–6.7)
.5841
D/C b-blockade 9.7
(9.0–10.4)
11.3
(8.8–13.8)
9.7
(8.3–11.1)
9.7
(8.4–10.9)
9.6
(8.5–10.7)
9.1
(8.0–10.2)
9.9
(8.0–11.8)
.6695
D/C antilipids 11.6
(10.6–12.5)
13.6
(10.9–16.3)
10.8
(9.2–12.5)
11.8
(9.9–13.6)
11.2
(9.6–12.9)
11.5
(10.0–13.1)
11.5
(9.3–13.7)
.7282
CI, Confidence interval; ITA, internal thoracic artery; DSWI, deep sternal wound infection; D/C, discharge.
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Dcategories. Of the 733 STS-participant hospitals in this 2007
study cohort, 87.4% of hospitals performed fewer proce-
dures than the 450 CABG case threshold recommended by
Leapfrog, and 67.4% of the procedures were performed
by hospitals with volumes of less than this threshold.
A complete table of patient characteristics for each vol-
ume category is available on request. For most characteris-
tics, the absolute differences among volume categories
were small, although most were statistically significant be-
cause of the large sample size. Several were of both statisti-
cal and clinical interest. For example, the frequency of
Hispanic and Asian patients was significantly greater at
the lowest-volume programs compared with that at the high-
est-volume programs (11.2% vs 3.7%, P< .001). Reoper-
ative CABG was more prevalent at the largest compared
with the smallest programs (4.5% vs 2.8%, P < .001),
whereas patients in cardiogenic shock were more common
at the smallest programs (2.5% vs 1.8%, P<.001). The lat-
ter might reflect the difficulty in transferring such critically
ill patients to major tertiary centers in a timely fashion.
The use of preoperative intra-aortic balloon pumps wasThe Journal of Thoracic and Cahigher in the smallest compared with the largest programs
(9.9% vs 6.6%, P< .001), and this could reflect either
practice style or their slightly increased prevalence of cardio-
genic shock and emergency patients.
Table 1 also presents the unadjusted frequency of adverse
outcomes and process noncompliance stratified by hospital
volume category. The 2007 mortality rate (2.6%) for the
lowest-volume category (<100 cases) was only slightly
higher than the mortality (2.4%) for the highest-volume
group (>450 cases) in the most recent previous STS study.3
These findings are consistent with recently reported data
from the Nationwide Inpatient Sample8 showing progressive
improvements in CABG outcomes over time.
Mortality varied inversely with hospital volume group,
with an absolute mortality difference of 0.9% between the
lowest-volume (2.6%) and highest-volume (1.7%) cate-
gories (P for trend< .0001). The absolute difference in fail-
ure to use an ITA was 1% between the highest- and lowest-
volume categories (5.8% vs 6.8%, P trend ¼ .0456). There
was no statistically significant difference in overall morbid-
ity or perioperative medication use. The frequency ofrdiovascular Surgery c Volume 139, Number 2 275
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Dpostoperative renal failure decreased significantly with in-
creasing hospital volume (P ¼ .0314).
Figure 1 includes scatterplots of the unadjusted perfor-
mance domain results for each of the 733 hospitals, using
volume as a continuous rather than categorical variable.
Much of the outcomes variability at lower-volume programs
in all 4 plots is due to the sampling variation, a phenomenon
that is the basis for so-called ‘‘funnel plots.’’9
Table 2 shows the results of random-effects logistic re-
gression modeling accounting for clustering and case mix.
Compared with the results for the 450 or greater case group,
the adjusted odds ratios for mortality were inversely related
to volume and were statistically significant for each volume
category except 150 to 199 procedures. The largest adjusted
odds ratio was in the lowest-volume category (1.49; 95%
CI, 1.24–1.80). For nonfatal end points and process measure
failures, only the odds ratio for renal failure in hospitals per-
forming less than 100 CABG procedures was significantly
greater than 1. There was a trend toward more consistent
ITA use in higher-volume hospitals (P ¼ .0237), but the
odds ratios for all individual volume categories included 1.FIGURE 1. Unadjusted rates for mortality (A), major morbidity (B), failure to
medications (D), plotting volume as a continuous variable. Each symbol indicate
pital procedures that included a coronary artery bypass grafting (CABG) procedu
procedures.
276 The Journal of Thoracic and Cardiovascular SurgIn a separate analysis of the 134 lowest-volume hospitals,
there was no difference between hospitals with above- and
below-average mortality in failure to use an ITA (6.7% vs
6.9%, P ¼ .55) or failure to use appropriate medications
(37.7% vs 39.1%, P ¼ .69).
Figure 2 shows the results of random-effects logistic re-
gression modeling with volume as a continuous variable in-
stead of a categorical variable. The plots of medication
compliance and overall morbidity are relatively horizontal,
and the CIs encompass an odds ratio of 1. ITA failure has
an inflection point at approximately 200 cases, but the CI
only exceeds 1 at extremely low volume. The odds ratio
for mortality increases monotonically with decreasing
volume, with an increase in slope at approximately 200 pro-
cedures.
Figure 3 presents the mean STS composite scores with
Bayesian 95% credible intervals for each volume category.
The entire CI of the lowest-volume category lies substantially
below the lower limits of the CIs for the 2 highest-volume cat-
egories. However, within each volume stratum, there is con-
siderable variability in composite scores, and the overalluse the internal thoracic artery (IMA) (C), and failure to use NQF-endorsed
s one of the 733 study hospitals. Volumes were determined by using all hos-
re, whereas the performance rates were calculated with only isolated CABG
ery c February 2010
TABLE 2. Adjusted performance ORs for hospitals in each volume category relative to hospitals with 450 or more annual CABG cases
OR for hospital volume category
<100 100–149 150–199 200–299 300–449
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) P value for trend
Domains
Operative mortality 1.49 (1.24–1.80) 1.28 (1.08–1.52) 1.14 (0.96–1.35) 1.31 (1.14–1.51) 1.17 (1.01–1.35) <.0001
Morbidity 1.09 (0.94–1.26) 1.03 (0.89–1.18) 1 (0.87–1.15) 1.02 (0.90–1.16) 1.03 (0.90–1.18) .3983
ITA failure 1.18 (0.93–1.50) 1.14 (0.9–1.44) 1.04 (0.82–1.32) 1.11 (0.89–1.38) 0.87 (0.69–1.09) .0237
Medication failure 0.99 (0.81–1.20) 0.88 (0.72–1.07) 0.91 (0.74–1.11) 0.92 (0.76–1.10) 0.87 (0.72–1.06) .9432
Morbidity measures
Prolonged ventilation 1.08 (0.89–1.32) 1.04 ( 0.86–1.26) 0.95 (0.78–1.16) 1.02 (0.85–1.22) 1.02 (0.84–1.23) .4982
DSWI 0.85 (0.53–1.36) 1.31 (0.92–1.87) 0.77 (0.521–1.15) 0.76 (0.55–1.05) 1.08 (0.79–1.46) .8522
Stroke 1.00 (0.76–1.33) 0.97 (0.76–1.23) 1.17 (0.94–1.45) 1.07 (0.89–1.28) 1.05 (0.88–1.27) .8292
Renal failure 1.3 (1.05–1.60) 1.08 (0.89–1.32) 1.09 (0.89–1.32) 1.11 (0.93–1.32) 1.16 (0.96–1.39) .1088
Reoperation 1.10 (0.93–1.29) 1.01 (0.86–1.18) 1.02 (0.87–1.19) 1.01 (0.88–1.16) 1.07 (0.92–1.23) .6323
Medication failure
Preoperative b-blockade 0.94 (0.78–1.13) 0.92 (0.77–1.11) 0.92 (0.76–1.11) 0.94 (0.79–1.12) 0.83 (0.69–1.00) .9375
D/C antiplatelet medication 1.12 (0.86–1.46) 0.85 (0.65–1.10) 0.79 (0.60–1.03) 0.93 (0.73–1.18) 0.98 (0.76–1.27) .8993
D/C b-blockade 1.09 (0.87–1.37) 0.96 (0.77–1.20) 0.95 (0.76–1.20) 0.96 (0.78–1.19) 0.91 (0.73–1.14) .3458
D/C antilipid medication 1.14 (0.87–1.48) 0.90 (0.69–1.18) 0.98 (0.75–1.29) 0.95 (0.74–1.21) 0.97 (0.75–1.27) .5245
OR, Odds ratio; CABG, coronary artery bypass grafting; CI, confidence interval; ITA, internal thoracic artery; DSWI, deep sternal wound infection; D/C, discharge.
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ume was only 1%.
Figure 4 is a scatterplot of the composite scores of all 733
hospitals plotted against volume as a continuous rather than
categorical variable. Although composite scores are rather
symmetrically distributed around the mean for programs of
all sizes, the lowest scores occurred mainly among the
lower-volume programs.
Figure 5 depicts the star ratings calculated by STS for all
CABG composite score recipients.4,5 Smaller programs are
less likely to achieve either 1- or 3-star status, primarily be-
cause there is less certainty about their true underlying perfor-
mance. As volume increases, the number of 3-star programs
increases, both because their results become more reliable
and because their performance is higher on average. The num-
ber of 1-star programs remains relatively static.DISCUSSION
Volume and Mortality
Numerous reports over the past 3 decades have docu-
mented the existence of an inverse association between pro-
cedural volume (surgeon, hospital, or both) and mortality, at
least for more complex procedures.10 The magnitude and
shape of these associations vary by procedure, as do the
threshold levels for optimal performance.
CABG is performed more frequently than any other major
complex operation, and it has been the subject of numerous
volume–mortality studies. Compared with other complex
but less frequently performed procedures, such as esopha-
gectomy and pancreatectomy, most CABG studies have
shown a weaker3,10–15 or absent16,17 volume–outcome asso-
ciation. Studies from New York have consistently shownThe Journal of Thoracic and Caa significant inverse association,18 which might be related
to its long history of public reporting and limited number
of very low-volume programs. Conversely, in California,
a state with many low-volume hospitals and higher overall
CABG mortality, a CABG volume–outcome association
was no longer apparent after public report cards were
introduced, suggesting that all hospitals were stimulated to
improve performance.19
Although an overall volume–mortality association does
exist for CABG, there remains substantial mortality variabil-
ity within every volume stratum, especially at very low vol-
umes.9,10,13–15,20,21 High volume does not guarantee better
outcomes at any specific program, nor does low volume pre-
clude excellence.
As CABG volumes have decreased because of better
medical therapy and the increasing use of percutaneous cor-
onary intervention, there has been concern that outcomes
would deteriorate because of diminishing experience.22
However, overall CABG mortality has continued to de-
crease despite progressively lower volumes and increasing
patient severity.8,23 This might reflect both the relatively
weaker volume–outcome association for CABG compared
with other procedures and improvements in surgical tech-
niques, anesthesia, and perioperative care.24Volume and Use of Optimal Practices
Empirical studies of the association between volume and
use of evidence-based care processes are less numerous than
those for volume and mortality. The clinical importance of
an association between volume and process compliance is
also confounded by inconclusive evidence relating the latter
to outcomes.25–29rdiovascular Surgery c Volume 139, Number 2 277
FIGURE 2. Adjusted odds ratio plots (using restricted cubic spline models with reference¼ 500 CABG procedures) of mortality (A), major morbidity (B),
failure to use the internal thoracic artery (IMA) (C), and failure to use NQF-endorsed medications (D), plotting volume as a continuous variable. Each symbol
represents one of the 733 study hospitals plotted. Volumes were determined using all hospital procedures that included a coronary artery bypass grafting
(CABG) procedure, whereas the performance rates were calculated with only isolated CABG procedures. See text for interpretation.
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DA few surgical studies suggest that superior processes of
care might be used by higher-volume surgeons and hospitals,
although it is often difficult to differentiate the relative contri-
butions of volume versus specialty training and practice.30–38
Several clinical studies affirm the importance of opti-
mal operative and perioperative care processes in provid-
ing high-quality CABG care.39–43 Discharge prescription
of antiplatelet agents, lipid-lowering drugs, and b-block-
ade is based on innumerable studies demonstrating their
effectiveness in secondary prevention of atherosclerotic
progression.
Implications of the Current Study
The CABG volume–mortality association in this large,
nationally representative sample remains relatively weak
compared with that of other complex procedures, despite
progressively lower average CABG volumes. As a group,
the lowest-volume hospitals had significantly higher mortal-
ity rates. However, there was wide residual variability in out-
comes at all hospital volumes. Because of this variation,278 The Journal of Thoracic and Cardiovascular Surgvolume alone is a poor predictor of an individual hospital’s
true risk-adjusted mortality rate.
This study adds several new dimensions to our understand-
ing of various CABG volume associations. First, there was no
significant association between use of measured, evidence-
based processes of care and program volume. The only excep-
tion was the significantP value (for trend) of the adjusted odds
ratios for ITA nonuse, although the 95%CIs of the odds ratios
for all individual volume categories included 1. This suggests
that these measured CABG processes are applicable across the
broad spectrum of program volumes, including small pro-
grams. In fact, it might be the widespread application of
such care processes that explains the excellent results achieved
by many lower-volume CABG programs in the United States,
Japan, and elsewhere.10,12,13,44
Given that a CABG volume–mortality association was
observed in this study, one might have expected that this
would be accompanied by a parallel association between
process compliance and volume. Although this was not ob-
served, it does not diminish the importance of using optimalery c February 2010
FIGURE 3. Average Society of Thoracic Surgeons (STS) composite score
(95% confidence interval [CI]) by volume category. CABG, Coronary ar-
tery bypass grafting.
FIGURE 5. Society of Thoracic Surgeons (STS) star rating by hospital to-
tal coronary artery bypass grafting (CABG) volume category. Solid line, 2
stars; large dashed line, 3 stars; small dashed line, 1 star.
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this study represent only a subset of the universe of
CABG care processes, which is generally true of most guide-
lines.45,46 Our data suggest that other unmeasured processes
of care, including overall team functioning, might be more
responsible for the volume–mortality association than the
4 NQF-endorsed measures we examined.
Our study is also one of the first to examine the association
of procedural volume and the incidence of major complica-
tions. The overall unadjusted occurrence of any major com-
plication varied little among all but the smallest and largest
CABG volume categories, and even for this most extreme
comparison, the spread was only 1.6% (13.2% vs 14.8%).
With the exception of renal failure in the smallest programs,
adjusted multivariable odds ratios revealed no statistically
significant association of any complications with volume.
The fact that complication rates did not vary by CABG vol-
ume, whereas mortality did demonstrate a volume associa-
tion, suggests that larger programs might ‘‘rescue’’ patients
more effectively from the sequelae of major complications.47
This is the first study of the association between hospital
CABG volume and performance on the multidimensionalFIGURE 4. Society of Thoracic Surgeons (STS) coronary artery bypass
grafting (CABG) composite score for all 733 study hospitals plotted against
total hospital CABG volume analyzed as a continuous variable. Dotted line,
STS average.
The Journal of Thoracic and CaSTS composite performance score.4,5 Many stakeholders
regard this as the most sensitive and comprehensive overall
measure of provider CABG quality. STS studies have shown
that it is much more discriminating of quality differences
among providers than mortality alone, although mortality is
a major driver of composite scores because of standardization
used in composite score construction.4 Average CABG com-
posite scores in this study were significantly lower for the low-
est-volume group compared with the 2 highest-volume groups.
Analyzing volume as a continuous variable, the lowest hospital
composite scores were associated with very low-volume pro-
grams, and no higher-volume hospitals had such low scores.
Finally, our study demonstrates that there are fewer low-
volume programs that achieve either better or worse than av-
erage star ratings using the STS composite, primarily because
there is insufficient sample size to reliably differentiate their
performance. Interestingly, the percentage of high-perfor-
mance programs increases steadily above the 200 to 299
CABG case category, whereas the percentage of low-per-
forming programs remains relatively constant. Within each
volume stratum, there are about 10% to 15% of programs
with composite performance below that of the STS average.Limitations
Although broadly representative of national practice and
encompassing a large majority of US programs, the STS
ACDB is voluntary. It is possible that some low-volume,
underperforming programs chose not to participate, which
could skew the results of our analyses. Nonetheless, the
high penetration (roughly 80% in 2007 and currently
>90%) of the STS database among US cardiac surgery pro-
grams argues against this as a major concern.
Despite our best efforts, it is possible that some STS hospital
CABG volumes could be inaccurate because this study re-
quired manual reclassification of STS participant data to the
hospital level. A participant is often a hospital, but occasion-
ally more than 1 STS participant surgeon or group mightrdiovascular Surgery c Volume 139, Number 2 279
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Dpractice at one institution. Overall, any volume inaccuracies in
this study, which is based on a robust clinical data registry en-
compassing all age groups and payers, are likely to be less than
those for studies derived from administrative data.
Only a small proportion of STS participant programs are
audited annually, but the results of such audits have gener-
ally shown good overall coding accuracy. For most hospital
CABG volume categories, about 90% of 30-day deaths in
the STS database occur in the hospital, and these deaths
are captured with 99% accuracy. Ascertainment of operative
deaths occurring after discharge but within 30 days is more
problematic, and this issue is currently the subject of an en-
hanced audit initiative.
Finally, the unit of inference for this study is the hospital.
We did not examine surgeon–volume associations or the po-
tential interaction between surgeon and hospital, both of
which might have important ramifications.18,48CONCLUSIONS
Although these findings demonstrate relatively stable per-
formance over a wide range of CABG volumes, they do sug-
gest the need to carefully scrutinize the performance of the
lowest-volume hospitals. Although there are many excellent
programs within this group, on average, their performance is
the most problematic.3,10,12,13,18 Strategies for measuring
and optimizing performance at such low-volume programs
have been described.12,13
Efforts should continue to accurately measure risk-ad-
justed outcomes and adherence to existing best practices; to
identify additional evidence-based, optimal care processes
through registry-based research; and to apply such optimal
care processes uniformly across programs of all sizes.References
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95% CI) were determined for each volume category, and
the proportion of variation in the composite scores explained
by volume was calculated.
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The model used for the composite score determination dif-
fers from the other models described in this study: (1) all 4
quality domains are analyzed jointly in a single model; (2)
the model has a single coefficient for volume rather than
a separate volume coefficient for each end point; and (3)
the model was estimated by using hospital-aggregated sum-
mary data (to facilitate computation) instead of individual
patient-level data. At each hospital, the number of ‘‘fail-
ures’’ of each type (mortality, morbidity, ITA noncompli-
ance, and medication noncompliance) was assumed to
depend on volume, case mix (mortality and morbidity
only), and a hospital-specific random-effects parameter.
The inclusion of hospital-specific random effects is intended
to capture variation in performance that is not explained by
volume, case mix, or chance. The model is as follows:
logit pmortj ¼ amortþbvoljþgmortlogit xmortj þ 3mortj
logit pmorbj ¼ amorbþbvoljþgmorblogit xmorbj þ 3morbj
logit pimaj ¼ aimaþbvoljþ3imaj
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Dr T. Bruce Ferguson (Greenville, NC). Thank you, Dr Patter-
son. I have no disclosures. This study extends the CABG volume–
outcome relationship beyond mortality alone to an evaluation of
morbidity and processes of care. Among the most sophisticated
of STS database analyses thus far, I congratulate Dr Shahian and
his coworkers on this work. This analysis highlights what we all
know: it is very difficult to provide continuous, highest-quality de-
livery of standardized care practices unless you ‘‘keep your edge.’’
Although the magic number for annual CABG volume is unknown,
re-examination in light of overall decreasing CABG volumes na-
tionwide is merited. However, the lack of variability across the
country is all the more remarkable when compared with the 10-
fold differences in procedure volume for CABG. This is a direct tes-
tament to the deliberate focus on measuring and disseminating best
practices by our specialty and in moving beyond risk-adjusted out-
comes to processes of care. I have 2 questions for Dr Shahian.
First, the composite score domains–adjusted odds ratio shows
differences in hospital mortality and ITA use but not in morbidity
and medication failure. Because ITA use has been linked to im-
proved short- and long-term mortality and because both ITA use
and, to a degree, hospital mortality are surgeon dependent, does
your analysis suggest that individual provider–level evaluation
rather than hospital-level evaluation is inevitable?
Second, STS risk-adjusted mortality and morbidity have been
stable over the past 3 years and have not continued to decrease.
The 2 lowest-volume groups comprise only 14.4% of the total pa-
tients undergoing CABG, and incremental improvement in their
outcomes through whatever mechanism is not likely to affect these
national benchmarks. What is next for CABG quality improve-
ment? Thank you.
Dr Shahian. Thank you very much, Bruce. With regard to the
first question about individual surgeon– versus hospital-level per-
formance evaluation, our professional societies have historically
focused on the latter. However, there are numerous reports from
Ed Hannan in New York, as well as a paper presented 2 years
ago at this meeting by Joe Carey from California, suggesting that
the surgeon and his or her relationship with the rest of the teamrdiovascular Surgery c Volume 139, Number 2 281
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Bruce, you have mentioned one performance metric, use of the
ITA, in which surgeons are completely in charge of an important
process metric, and there are very few legitimate reasons not to
use an ITA graft.
So how do we best incorporate surgeon performance into an
overall quality-monitoring paradigm while hopefully not causing
surgeons to become risk averse? Like politics, I think this might
be best conducted locally, at least initially. For example, a hospital
chief of cardiac surgery or the leader of a practice group would
carefully review his or her performance reports from the STS data-
base, notice a low score resulting from suboptimal ITA use, drill
down internally to the surgeon level, and then discuss this with
the appropriate staff. As a profession, we have been rather reluctant
to have those kinds of difficult conversations. However, if we do
not accept this responsibility, then others will force the issue, and
the result will be even more onerous.
Your second question involved where we go from here in
quality improvement. First, I would not discount the value of
focusing some improvement efforts on the 2 lowest-volume
hospital categories. Even though they cared for only 14% of
the patients in our series, they include about 36% of hospitals
overall and their performance in most areas appears inferior to
that of larger hospitals.
So what do I think we need to be doing in the quality assurance
and improvement areas? First, we need to develop a broader port-
folio of evidence-based processes of care that is much more com-
prehensive than we currently measure. We need to implement
these nationally using state and regional peer collaboration, and
we need to reduce the variability that currently exists for many of
such measures. We also need enhanced performance monitoring,
particularly in the low-volume programs, where this is so problem-
atic. I personally think that tertiary sponsorship or oversight of the282 The Journal of Thoracic and Cardiovascular Surglowest-volume programs is very important, and this is a model that
has worked well in Massachusetts. Finally, I think there are some
extremely low-volume programs for which regionalization would
be a better option. Thank you.
Dr Craig R. Smith (New York, NY). Very simply, did you look
at geography as a variable at all, state or region, or, more interest-
ingly, is rural low volume the same as urban low volume?
Dr Shahian. We did not look at that, but it would be an excellent
next step.
Dr JohnD. Puskas (Atlanta, Ga). David, I enjoyed your presen-
tation. Did you have a chance to look at the effect of low- or
high-volume centers on mortality and morbidity after off-pump
compared with on-pump surgery? We are still in an era in which
many consider that a more technically demanding operation.
Does an institution or surgeon need to be doing more of it to hit
a decent benchmark in quality?
Dr Shahian. John, we did not do that, but it would be an excel-
lent follow-on study. You are absolutely correct that it is a very in-
teresting and important area to investigate.
Dr Marc R. Moon (St Louis, Mo). You said that the ITA use
was lowest in the low-volume centers but also that the acuity was
the highest. Are you sure there was not a relationship between
lack of ITA use and patients being sicker when they went for sur-
gical intervention?
Dr Shahian. Well, the trend adjusted for acuity still showed the
same finding. Granted, the absolute differences are small. For all
these differences, many of them are statistically significant because
we have such a large sample size, but there was about a 1% or 2%
difference, and the lowest use among all programs—and some of
them had very low use rates—were at the low-volume end. We
had some programs with 70% or 60% ITA use, and they are all
at the low end of the volume spectrum. I do not think that is com-
pletely accounted for by acuity or other factors.ery c February 2010
